Cancer is the second leading cause of death worldwide. The World Health Organization (WHO) estimates there will be 50% more new cancer cases in 2040 than there are today. Novartis is committed to unraveling the inner workings of cancer and developing new therapies for a range of common and rare cancers, investing in diverse technology platforms and experimenting with combination approaches.

Reimagining medicine in cancer

We have the passion and the people to help transform lives as we pursue treatments for patients.



Related links

Learn more about the other Novartis core therapeutic areas